artenimol has been researched along with Nasopharyngeal Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Y; Tang, X; Wang, J; Wang, L; Xu, J; Yang, H; Yang, Y; Zhou, C; Zhu, L | 1 |
| Huang, B; Huang, X; Huang, Z; Jiang, D; Luo, G; Zhang, Y | 1 |
2 other study(ies) available for artenimol and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Opening of the CLC-3 chloride channel induced by dihydroartemisinin contributed to early apoptotic events in human poorly differentiated nasopharyngeal carcinoma cells.
Topics: Apoptosis; Artemisinins; Blotting, Western; Cell Line; Cell Survival; Chloride Channels; Flow Cytometry; Humans; Nasopharyngeal Carcinoma; RNA, Small Interfering | 2018 |
[Apoptosis of nasopharyngeal carcinoma cells line CNE-2 induced by dihydroartemisinin and its possible mechanism].
Topics: Apoptosis; Artemisinins; Carcinoma; Caspase 3; Cell Line, Tumor; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2013 |